|
시장보고서
상품코드
2050886
분자진단 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Molecular Diagnostics Market, By Product Type, By Application, By End-User, By Geography |
||||||
분자진단 시장은 2026년에 206억 7,000만 달러로 추정되고, 2033년에 474억 4,000만 달러에 이를 것으로 예상되고 있습니다. 또한, 2026-2033년 CAGR 12.6%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 206억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 12.60% | 2033년 시장 규모 예측 : | 474억 4,000만 달러 |
분자진단은 질병 검사, 위험 예측 또는 새로운 치료법 발굴을 목적으로 분자 수준에서 생물학적 마커(바이오마커)를 분석하는 분야로 계속 진화하고 있는 분야입니다. 분자진단은 현대 의학의 기본 도구가 되어 임상의가 질병을 감지하고 모니터링하며 치료 방침을 결정하는 데 도움을 주고 있습니다. DNA 시퀀싱, 중합효소연쇄반응(PCR) 등의 기술을 통해 바이오마커를 검출할 수 있게 된 것은 의료 검사에 혁명을 가져왔고, 환자의 예후를 크게 개선했습니다. 분자진단 기술의 발전과 유전자 염기서열 분석 비용의 하락이 맞물려 감염 검사, 종양학, 맞춤형 의료 등 다양한 응용 분야에서의 보급을 촉진하고 있습니다. 지속적인 연구개발을 통해 분석 능력을 더욱 확장하고 있으며, 이는 시장의 지속적인 확대에 기여할 것으로 예측됩니다.
시장 역학
세계 분자진단 시장은 몇 가지 요인에 힘입어 강력한 성장세를 보이고 있습니다. 전 세계적으로 만성질환 및 감염성 질환의 유병률이 증가함에 따라 첨단 진단 기술에 대한 요구가 증가하고 있습니다. 분자진단 검사는 기존 방식에 비해 보다 빠르고 정확한 질병을 조기에 발견할 수 있습니다. 분자 검사는 환자 개개인에게 가장 효과적인 치료법을 찾아내는 데 도움이 되기 때문에 맞춤형 의료 및 동반 진단에 대한 수요가 증가하는 것도 또 다른 주요 촉진요인으로 작용하고 있습니다. 고성능 스크리닝, 자동화된 워크플로우 프로세스, 분산형 검사 환경을 가능하게 하는 기술의 발전으로 분자진단의 역량이 확대되고 있습니다. 그러나 높은 장비 비용과 숙련된 인력의 부족이 시장 성장을 억제하고 있습니다. 시퀀싱 비용의 지속적인 하락과 함께 휴대가 간편하고 사용하기 쉬운 기기의 개발이 진행됨에 따라, 특히 분산형 및 포인트 오브 케어(PoC) 환경에서 새로운 응용 분야에서의 기회가 열리고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계 분자진단 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기계 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 분자진단 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 분자진단 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 분자진단 시장 : 제품 유형별, 2026-2033년
제5장 세계의 분자진단 시장 : 용도별, 2026-2033년
제6장 세계의 분자진단 시장 : 최종사용자별, 2026-2033년
제7장 세계의 분자진단 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌과 조사 방법
LSH 26.06.15Molecular Diagnostics Market is estimated to be valued at USD 20.67 Bn in 2026 and is expected to reach USD 47.44 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 20.67 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.60% | 2033 Value Projection: | USD 47.44 Bn |
Molecular diagnostics is an evolving field that involves the analysis of biological markers, or biomarkers, at the molecular level to test for diseases, predict risk or identify new therapeutic options. Molecular diagnostics has become a fundamental tool in modern healthcare, helping clinicians detect and monitor disease along with making treatment decisions. The ability to detect biomarkers through techniques such as DNA sequencing and polymerase chain reaction (PCR) has revolutionized medical testing and significantly improved patient outcomes. Advances in molecular diagnostic techniques coupled with the declining costs of genetic sequencing are helping drive widespread adoption across various applications areas such as infectious disease testing, oncology and personalized medicine. Continued research and development is further expanding analytical capabilities which is expected to contribute to the ongoing expansion of the market.
Market Dynamics
The global molecular diagnostics market is witnessing strong growth driven by several factors. Rising prevalence of chronic and infectious diseases worldwide have increased the need for advanced diagnostic techniques. Molecular diagnostic tests offer earlier, more accurate detection of diseases compared to conventional methods. Growing demand for personalized medicine and companion diagnostics is another key driver as molecular tests help identify the most effective therapies for individual patients. Technological advancements enabling high-throughput screening, automated workflow processes and decentralized testing environments are expanding molecular diagnostic capabilities. However, high costs of instruments and lack of skilled labor restrain the market growth. Ongoing reductions in sequencing costs along with the development of portable, easy-to-use instruments opens opportunities in new applications areas, especially in decentralized, point-of-care settings.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global molecular diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin SPA, Hologic Inc., QIAGEN N.V., Roche Diagnostics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global molecular diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global molecular diagnostics market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2026 - 2033)
- Reagents & Kits
- Instruments
- Application Insights (Revenue, USD Bn, 2026 - 2033)
- Oncology
- Genetic Testing
- Microbiology
- STDs
- Blood Screening
- Virology
- Tissue Typing
- Prenatal Diagnosis
- Others
- End-user Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Point-of-Care Settings
- Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- Hologic, Inc.
- Agilent Technologies Inc.
- Qiagen N.V.
- Myriad Genetics
- Becton, Dickinson and Company
- Abbott Laboratories
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- Danaher Corporation (Beckman Coulter Inc.)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Johnson & Johnson
- Alere Inc.
- Cepheid
- Gen-Probe Incorporated
- LabCorp (Monogram Biosciences)
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Molecular Diagnostics Market, By Product Type
- Global Molecular Diagnostics Market, By Application
- Global Molecular Diagnostics Market, By End-User
- Global Molecular Diagnostics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Molecular Diagnostics Market, By Product Type, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
5. Global Molecular Diagnostics Market, By Application, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Microbiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- STDs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Blood Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Virology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Tissue Typing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Prenatal Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
6. Global Molecular Diagnostics Market, By End-User, 2026 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospitals and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Point-of-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
7. Global Molecular Diagnostics Market, By Region, 2026 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026,2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2026 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application , 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End-User , 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Agilent Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation (Beckman Coulter Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alere Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gen-Probe Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LabCorp (Monogram Biosciences)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
